Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Point-of-Care Anti-CD19 CAR-T for B-cell Malignancies
NCT06462248Phase 2Recruiting
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CUCART19 in acute lymphoblastic leukemia (ALL), B-cell non-Hodgkin lymphoma. Started Jun 2024; status: recruiting.
02
Drugs
CUCART19
03
Conditions
acute lymphoblastic leukemia (ALL)B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT06462248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06462248.